Defining the spatial landscape of KRAS mutated congenital pulmonary airway malformations: a distinct entity with a spectrum of histopathologic features.
Defining the spatial landscape of KRAS mutated congenital pulmonary airway malformations: a distinct entity with a spectrum of histopathologic features.
复制标题
DOI:
10.1038/s41379-022-01129-0
复制
发表时间:
2022-12
期刊:
影响因子:
7.5
通讯作者:
Pogoriler, Jennifer
中科院分区:
文献类型:
--
作者:
Nelson, Nya D.;Xu, Feng;Chandrasekaran, Prashant;Litzky, Leslie A.;Peranteau, William H.;Frank, David B.;Li, Marilyn;Pogoriler, Jennifer
The potential pathogenetic mechanisms underlying the varied morphology of congenital pulmonary airway malformations (CPAMs) have not been molecularly determined, but a subset have been shown to contain clusters of mucinous cells (MCC). These clusters are believed to serve as precursors for potential invasive mucinous adenocarcinoma, and they are associated with KRAS codon 12 mutations. To assess the universality of KRAS mutations in MCCs, we sequenced exon 2 of KRAS in 61 MCCs from 18 patients, and we found a KRAS codon 12 mutation in all 61 MCCs. Furthermore, all MCCs from a single patient always had the same KRAS mutation, and the same KRAS mutation was also found in non-mucinous lesional tissue. Next generation sequencing of seven MCCs showed no other mutations or copy number variations. Sequencing of 46 additional CPAMs with MCCs revealed KRAS mutations in non-mucinous lesional tissue in all cases. RNA in situ hybridization confirmed widespread distribution of cells with mutant KRAS RNA, even extending outside of the bronchiolar type epithelium. We identified 25 additional CPAMs with overall histologic architecture similar to CPAMs with KRAS mutations but without identifiable MCCs, and we found KRAS mutations in 17 (68%). The histologic features of these KRAS mutated CPAMs included type 1 and type 3 morphology, as well as lesions with an intermediate histologic appearance, and analysis revealed a strong correlation between the specific amino acid substitution and histomorphology. These findings, together with previously published model organism data, suggests that the formation of type 1 and 3 CPAMs is driven by mosaic KRAS mutations arising in the lung epithelium early in development and places them within the growing field of mosaic RASopathies. The presence of widespread epithelial mutation explains late metastatic disease in incompletely resected patients and reinforces the recommendation for complete resection of these lesions.
登录
查看更多内容
影响因子:
18.4
作者:
Haigis KM
通讯作者:
Haigis KM
影响因子:
3.3
作者:
Hermelijn, Sergei M.;Wolf, Janina L.;von der Thusen, Jan H.
通讯作者:
von der Thusen, Jan H.
影响因子:
3.1
作者:
Koopman, Timco;Rottier, Bart L.;Timens, Wim
通讯作者:
Timens, Wim
DOI:
10.1158/1078-0432.ccr-21-0423
发表时间:
2021-07-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Chang JC;Offin M;Falcon C;Brown D;Houck-Loomis BR;Meng F;Rudneva VA;Won HH;Amir S;Montecalvo J;Desmeules P;Kadota K;Adusumilli PS;Rusch VW;Teed S;Sabari JK;Benayed R;Nafa K;Borsu L;Li BT;Schram AM;Arcila ME;Travis WD;Ladanyi M;Drilon A;Rekhtman N
通讯作者:
Rekhtman N
DOI:
10.1165/rcmb.2007-0290oc
发表时间:
2008-09-01
影响因子:
6.4
作者:
Gonzaga, Silvia;Henriques-Coelho, Tiago;Flake, Alan W.
通讯作者:
Flake, Alan W.